More on ILMN
Data
Financials
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $128.24 |
|
|||
| Open | $126.74 | ||||
| 52 Wk High | $196.47 | ||||
| 52 Wk Low | $127.10 | ||||
| Day High | $127.75 | ||||
| Day Low | $124.06 | ||||
| P/E | 138.47 | ||||
| EPS | $0.90 | ||||
| Volume | 1,477,734 | ||||
- Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
- Illumina partners with Florida State University for rare disease testing
- Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
- Evercore ISI: 'We believe ILMN shares are set for a relief rally'
- Wolfe: 'Roche Consumables Priced at $150/genome, Though There Are Some Nuances/Limits?; Launch Mid-2026'
- Canaccord: 'Roche ups the ante with $150 genome and reusable chips (20x); may prove formidable vs. ILMN; HOLD'
- Illumina announces cancer research advances using multiomics technologies
- Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
- Form 4 ILLUMINA, INC. For: Feb 20 Filed by: Davies Scott M
- Illumina launches TruPath Genome sequencing technology
Entities mentioned with ILMN
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- Twitter | View Related Stories »
- ARK | View Related Stories »
- FDA | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- Carl Icahn | View Related Stories »
- Show More...
